Sign in
4

Changes in Ownership

GENELUX Corp Filed Acc 0001415889-24-029742

VP, Pharmaceutical Development sold 6,300 shares at $2.34 ($14,742)

From the SEC's structured data for this filing

Trades in this filing

Cappello Joseph · VP, Pharmaceutical Development

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-12-16 Sale : show line 1 in the form −6,300 $2.34 $14,742 14,653 D
Open-market sales · 6,300 sh · avg $2.34 · $14,742
Loading xslF345X05/form4-12182024_041204.xml…